STRATA Skin Sciences Inc
$ 0.14
5.16%
14 Apr - close price
- Market Cap 765,470 USD
- Current Price $ 0.14
- High / Low $ 0.14 / 0.11
- Stock P/E N/A
- Book Value 0.49
- EPS -1.35
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.11 %
- ROE -1.59 %
- 52 Week High 3.86
- 52 Week Low 0.11
About
STRATA Skin Sciences, Inc., a medical technology company, develops, markets and markets products for the treatment of dermatological conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company is headquartered in Horsham, Pennsylvania.
Analyst Target Price
$10.80
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-13 | 2025-08-14 | 2025-04-28 | 2025-03-25 | 2024-11-12 | 2024-08-14 | 2024-05-15 | 2024-03-27 | 2023-11-14 | 2023-08-09 | 2023-05-15 | 2023-03-31 |
| Reported EPS | -0.36 | -0.6 | -0.58 | 0.2872 | -0.5207 | -0.03 | -0.1 | -0.11 | -0.03 | -0.06 | -0.08 | 0.045 |
| Estimated EPS | 0.03 | 0.01 | -0.56 | -0.4 | -0.44 | -0.7 | -0.07 | -0.02 | -0.04 | -0.05 | -0.07 | -0.05 |
| Surprise | -0.39 | -0.61 | -0.02 | 0.6872 | -0.0807 | 0.67 | -0.03 | -0.09 | 0.01 | -0.01 | -0.01 | 0.095 |
| Surprise Percentage | -1300% | -6100% | -3.5714% | 171.8% | -18.3409% | 95.7143% | -42.8571% | -450% | 25% | -20% | -14.2857% | 190% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SSKN
2026-04-07 05:54:28
The global Dermatology Excimer Laser Market is projected to reach US$ 1,232.15 million by 2032, growing at a CAGR of 10.3% from its US$ 625.48 million valuation in 2025. This growth is driven by increasing prevalence of skin disorders, technological advancements, and a rising demand for non-invasive dermatological treatments. Key players in this market include STRATA Skin Sciences, Inc., Shenzhen GSD Tech Co., Ltd., and Alma Lasers, with recent industry developments highlighting significant mergers, acquisitions, and expanded applications of excimer laser therapy.
2026-03-26 10:09:46
STRATA Skin Sciences reported fiscal 2025 net revenue of $30.7 million, a 9% decline from the previous year, and a net loss of $6.3 million, which is a 38% improvement. The decline in revenue was primarily due to lower international equipment sales, while recurring procedures remained stable. The company also increased its direct-to-patient marketing efforts and expanded its U.S. sales team.
2026-03-22 08:38:52
This article examines the historical performance of Strata Skin Sciences Inc (SSKN) stock, detailing how a $1,000 investment would have fared over one, five, and ten years. It shows significant negative returns, with a $1,000 investment ten years ago being worth only $6 today. The article also provides an overview of Strata Skin Sciences, highlighting its focus on dermatologic medical devices like the XTRAC excimer laser and its recurring revenue model through a U.S. Partnership Program.
2026-03-08 12:52:26
This article reports on an SEC Filing (Form EFFECT) by STRATA Skin Sciences, Inc. (SSKN) with a filing impact and sentiment noted as neutral. The filing's effectiveness date was March 4, 2026, and it provides details on the accession number, submission type, CIK, company name, and file number. The report also includes recent news, SEC filings, and stock data for SSKN.
2026-03-05 23:10:58
STRATA Skin Sciences, Inc. (SSKN) filed an EFFECT form with the SEC, which became effective on March 4, 2026. This filing, related to submission type POS AM, indicates a neutral impact and sentiment according to Rhea-AI. The company, an OTC-listed medical device firm, has a market cap of $1.12 million and has recently announced its Nasdaq delisting, alongside updates on its XTRAC® and TheraclearX® products.
2026-03-04 23:08:39
STRATA Skin Sciences, Inc. (SSKN) filed an EFFECT Notice of Effectiveness with the SEC, which became effective on March 4, 2026. This filing, marked with a neutral impact and sentiment, provides details about the company's SEC submission. The document includes the accession number, submission type, and CIK, indicating its official status with regulatory bodies.
